NCT01332071View on ClinicalTrials.gov

Avandamet Bioequivalence Study Brazil - Fed Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 24, 2009

Primary Completion Date

December 6, 2009

Study Completion Date

December 6, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Rosiglitazone Maleate + Metformin 2 miligrams (mg) + 500 mg

Avandamet reference product

DRUG

Rosiglitazone Maleate + Metformin 4 miligrams (mg) + 1000 mg

Avandamet test product

Trial Locations (1)

Unknown

GSK Investigational Site, Goiânia

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY